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Chromosome 16 inversion, inv(16), is the signature chromosome abnormality in M4Eo subtype of acute myeloid leukemia (AML), which produces a fusion gene CBFB-MYH11. 1 We previously generated a knockin mouse model for CBFB-MYH11 (Cbfb +/MYH11 ). 2 Heterozygous Cbfb-MYH11 knockin mice have definitive hematopoiesis blockage and die at mid-gestation, which is similar to the phenotypes of Runx1 −/− and Cbfb −/− mice, 3, 4 indicating that CBFβ-SMMHC, the fusion protein encoded by Cbfb-MYH11, dominantly suppresses RUNX1 and CBFβ. Chimeric and conditional Cbfb-MYH11 knockin mice develop AML when they acquire additional mutations. 5 An important domain of CBFβ-SMMHC is the C-terminal region of SMMHC, which catalyzes homo-dimerization and multimerization of the fusion protein that may be functionally important. 6 To test the function of this region, we previously generated knockin mice that expressed a truncated CBFβ-SMMHC missing C-terminal 95 amino acids. These mice would not develop leukemia, indicating the importance of C-terminal region for leukemogenesis. 7 The CBFβ-SMMHC C-terminal region contains an assembly competence domain (ACD), which is important for SMMHC multimerization, 8, 9 as well as a transcriptional repression domain. [8] [9] [10] Specific amino acid residues in the helices D and E of ACD are important for multimerization of CBFβ-SMMHC but not for transcription repression. 8 To distinguish which domain is critical for the role of CBFβ-SMMHC in leukemia development, we generated the current mouse model with mutations in helices D and E of CBFβ-SMMHC to impair multimerization but leave the transcriptional repression domain intact.
Specifically, we mutated six charged residues of helices D and E to threonine, serine or alanine residues: D (NANRRKL to NSNRASL), E (QRELDEA to QAELTSA), as published previously. 8 We incorporated these mutations into the full length Cbfb-MYH11 knockin construct 2 (Supplementary Figure S1a ). Correct knockin was confirmed by Southern blot hybridization (Supplementary Figure S1b ) and the expression of the fusion protein CBFβ-SMMHC mDE was detectable in BM cells, at a level similar to CBFβ-SMMHC when compared to CBFβ (Supplementary Figure S1c ).
Mice carrying one copy of DE mutated Cbfb-MYH11 (Cbfb +/mDE ) developed normally through adulthood, while Cbfb mDE/mDE embryos died in mid-gestation with central nervous system hemorrhage ( Supplementary Table S1 ) and defective definitive hematopoiesis ( Supplementary Figures S2a and b ), similar to Cbfb +/MYH11 embryos. 2 However, Cbfb +/mDE and Cbfb mDE/mDE embryos did not develop primitive hematopoiesis defect (Supplementary Figures S2c-e) as seen in Cbfb +/MYH11 and Cbfb ΔC95/ΔC95 mice. 7 We observed Cbfb +/mDE mice for up to two years and did not see any notable abnormality. Their peripheral blood (PB) cells were largely normal except for decreased B cells and increased Mac1 + Gr-1 + myeloid cells in older mice (Supplementary Figure S3 ). Adult BM cells from Cbfb +/mDE mice showed no significant difference when compared to their wild-type littermates in lineage differentiation, colony forming ability, cell viability, total cell count and apoptosis, except a slight increase of apoptosis in Lin + cells ( Supplementary  Figures S4-S6 ). Importantly, none of the Cbfb +/mDE mice developed leukemia, even after treatment with ENU to induce additional mutations ( Figure 1a ).
It was shown previously that the DE mutations decreased the ability of CBFβ-SMMHC to form multimers and enter the nuclei. 8 We therefore examined the subcellular localization of endogenous CBFβ-SMMHC mDE in the knockin mice. Immunofluorescence staining of PB cells from E11.5 Cbfb mDE/mDE embryos showed that RUNX1 was mostly localized in the nuclei, while CBFβ-SMMHC mDE was localized in both nuclei and cytoplasm (Figures 1b and c) . On the other hand, RUNX1 and CBFβ were mostly co-localized in the nuclei of PB cells in WT embryos (Figures 1b and c) . These observations were confirmed by western blot, since more CBFβ-SMMHC mDE than CBFβ-SMMHC was detected in the cytoplasm of bone marrow cells from adult mice (Supplementary Figure S7a ). In addition, transfected 293 cells showed similar reduction of colocalization between RUNX1 and CBFβ-SMMHC mDE as well as more cytoplasmic localization of CBFβ-SMMHC mDE (Figures 1d and e ) and the western blot of transfected 293 cells ( Supplementary  Figure 7b ) confirmed the expression of transfected proteins. The reduced co-localization between RUNX1 and CBFβ-SMMHC mDE as well as more cytoplasmic localization of CBFβ-SMMHC mDE suggested that CBFβ-SMMHC mDE likely has reduced capacity to interact with RUNX1, which may be important for leukemogenesis by CBFβ-SMMHC. Even though Cbfb mDE/mDE and Cbfb +/MYH11 embryos had a similar phenotype at mid-gestation, they had very different gene expression patterns, with 188 and 1725 differentially expressed genes, respectively (FDR o 0.01, Fold-change42). Moreover, most differentially expressed genes in Cbfb +/MYH11 embryos were upregulated, while almost all differentially expressed genes in Cbfb mDE/mDE embryos were downregulated (Figure 2a ). Interestingly, canonical pathway and disease/biological functions were also affected in opposite directions in Cbfb mDE/mDE and Cbfb +/MYH11 embryos (Supplementary Figure S8) .
We performed RNA-Seq experiments to compare the expression profile of C-KIT + cells in the adult Cbfb +/mDE mice with C-KIT + cells in Cbfb +/MYH11 and WT mice. As shown in Figure 2b , gene expression profile of Cbfb +/mDE cells overlapped with that of WT cells, but differed from Cbfb +/MYH11 cells. There were 5641 differentially expressed genes (FDRo0.05, Fold-change ⩾ 1.5) in Cbfb +/MYH11 cells, compared to the WT cells, accounting for 36.46% of all expressed genes. Between Cbfb +/mDE and WT cells, only 82 genes (82 of 14932, 0.55%) were differentially expressed (Figure 2c ). Among the 82 differentially expressed genes in the Cbfb +/mDE cells, 50 (60%) ( Supplementary Table S2 ) were also differentially expressed in the Cbfb +/MYH11 cells (Figure 2d) . Interestingly, some genes were differentially expressed in opposite directions, for example, Socs2 was 2 × down in Cbfb +/mDE cells, but 17.6 × up in Cbfb +/MYH11 cells ( Supplementary Table S2 ).
Furthermore, Cbfb +/MYH11 cells expressed significantly higher number of genes, while Cbfb +/mDE cells expressed similar number of genes as the WT cells (Figure 2e and Supplementary Figure S9 ). In addition, MYH11 and MYH11 mDE expression was detected in Cbfb +/ MYH11 and Cbfb +/mDE cells, respectively, from the RNA-Seq data.
Overall, our data demonstrated that the C-terminal multimerization domain, especially the 6 charged aa residues, is essential for leukemogenesis by CBFβ-SMMHC. The mechanism is still unclear, but likely through reduced RUNX1 sequestration, leading to fewer gene expression changes. Our findings point to an important target for developing specific therapeutic approaches for this type of leukemia.
